Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023 U.S. Preventive Services Task Force (USPSTF) Guidelines
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · fourth_quarter · Q4
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
Source: Senate LDA
PREVENT HPV Cancers Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023
PREVENT HPV Cancers Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · third_quarter · Q3
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · second_quarter · 2A
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · second_quarter · Q2
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · fourth_quarter · Q4
Issues related to medical device reimbursement
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · third_quarter · Q3
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · second_quarter · Q2
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023 U.S. Preventive Services Task Force (USPSTF) Guidelines
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · first_quarter · Q1
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE